APA (7th ed.) Citation

F, C., L, Z., Z, Z., X, S., J, X., Z, Y., . . . J, X. (2024). TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients. Frontiers in immunology, 15, 1408406. https://doi.org/10.3389/fimmu.2024.1408406

Chicago Style (17th ed.) Citation

F, Cao, et al. "TM9SF1 Offers Utility as an Efficient Predictor of Clinical Severity and Mortality Among Acute Respiratory Distress Syndrome Patients." Frontiers in Immunology 15 (2024): 1408406. https://doi.org/10.3389/fimmu.2024.1408406.

MLA (9th ed.) Citation

F, Cao, et al. "TM9SF1 Offers Utility as an Efficient Predictor of Clinical Severity and Mortality Among Acute Respiratory Distress Syndrome Patients." Frontiers in Immunology, vol. 15, 2024, p. 1408406, https://doi.org/10.3389/fimmu.2024.1408406.